Early switch from intravenous to oral antibiotic therapy in patients with cancer who have low-risk neutropenic sepsis (the EASI-SWITCH trial): study protocol for a randomised controlled trial

BACKGROUND: Neutropenic sepsis remains a common treatment complication for patients receiving systemic anti-cancer treatment. The UK National Institute for Health and Care Excellence have not recommended switching from empirical intravenous antibiotics to oral antibiotics within 48 h for patients as...

Descripción completa

Detalles Bibliográficos
Autores principales: Forde, Caroline, McMullan, Ronan, Clarke, Mike, Wilson, Richard H., Plummer, Ruth, Grayson, Margaret, McDowell, Cliona, Agus, Ashley, Doran, Annmarie, McAuley, Danny F., Thomas, Anne L., Barnes, Rosemary A., Adams, Richard, Chau, Ian, Coyle, Vicky
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7251886/
https://www.ncbi.nlm.nih.gov/pubmed/32460818
http://dx.doi.org/10.1186/s13063-020-04241-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7251886/
https://www.ncbi.nlm.nih.gov/pubmed/32460818
http://dx.doi.org/10.1186/s13063-020-04241-1

Ejemplares similares